Clinical Trial: NCT03210714
Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)
Status:
ACTIVE NOT RECRUITINGPhase:
Phase 2| Lead Sponsor: | National Cancer Institute (NCI) |
| Information Provided By: | National Cancer Institute (NCI) |
| Last Update Posted: | 2026-11-13 |
Study Overview
Brief Summary
This phase II Pediatric MATCH trial studies how well erdafitinib works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with FGFR mutations that have spread to other places in the body and have come back or do not respond to treatment. Erdafitinib may stop the growth of cancer cells with FGFR mutations by blocking some of the enzymes needed for cell growth.
Official Title
Conditions
Intervention / Treatment
- Procedure: Biospecimen Collection
- Procedure: Bone Marrow Aspiration and Biopsy
- Procedure: Bone Scan
- Procedure: Computed Tomography
- Drug: Erdafitinib
- Other: Laboratory Biomarker Analysis
- Procedure: Magnetic Resonance Imaging
- Other: Pharmacological Study
- Procedure: Positron Emission Tomography
- Procedure: Radionuclide Imaging
- Procedure: X-Ray Imaging
Other Study ID Numbers
- NCI-2017-01159
- NCI-2017-01159
- APEC1621B
- APEC1621B
- U10CA180886
- UM1CA081457
Start Date (Actual)
Primary Completion Date (Actual)
Study Completion Date (Estimated)
Enrollment (Actual)
Study Type
Phase
| Lead Sponsor: | National Cancer Institute (NCI) |
| Information Provided By: | National Cancer Institute (NCI) |
| Last Update Posted: | 2026-11-13 |
Study Overview
Brief Summary
This phase II Pediatric MATCH trial studies how well erdafitinib works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with FGFR mutations that have spread to other places in the body and have come back or do not respond to treatment. Erdafitinib may stop the growth of cancer cells with FGFR mutations by blocking some of the enzymes needed for cell growth.
Official Title
Conditions
Intervention / Treatment
- Procedure: Biospecimen Collection
- Procedure: Bone Marrow Aspiration and Biopsy
- Procedure: Bone Scan
- Procedure: Computed Tomography
- Drug: Erdafitinib
- Other: Laboratory Biomarker Analysis
- Procedure: Magnetic Resonance Imaging
- Other: Pharmacological Study
- Procedure: Positron Emission Tomography
- Procedure: Radionuclide Imaging
- Procedure: X-Ray Imaging
Other Study ID Numbers
- NCI-2017-01159
- NCI-2017-01159
- APEC1621B
- APEC1621B
- U10CA180886
- UM1CA081457